TK
Teja Kalyani Ghanta
About Teja Kalyani Ghanta
Data last updated:
Teja Kalyani Ghanta has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Cloudcrush Private Limited and Tlabs Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Tlabs Pharma Private Limited at ₹34.1 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Jul 2023 | 2020 | ₹34.1 Lakh (FY 2024) | Active | |
| Director | 11 Nov 2019 | 2019 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Teja Kalyani Ghanta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Teja Kalyani Ghanta
Teja Kalyani Ghanta has 6 years in corporate governance. Holds Director role. Currently with 2 companies, including Cloudcrush Private Limited and Tlabs Pharma Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Tlabs Pharma Private Limited at ₹34.1 Lakh (FY 2024).
Teja Kalyani Ghanta is associated with 2 companies as Director, including Tlabs Pharma Private Limited (₹34.1 Lakh), Cloudcrush Private Limited.
Teja Kalyani Ghanta has expertise in General Business.
Teja Kalyani Ghanta has 6 years in corporate governance.
By reported revenue, the largest current company of Teja Kalyani Ghanta is Tlabs Pharma Private Limited, with revenue of ₹34.1 Lakh (FY 2024).
Teja Kalyani Ghanta currently holds positions at 2 companies: Tlabs Pharma Private Limited (₹34.1 Lakh), Cloudcrush Private Limited.